Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01891422 · ClinicalTrials.gov registry record
Longitudinal Studies of the Glycoproteinoses
A clinical trial, sponsored by Greenwood Genetic Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT01891422 is a clinical trial that has completed, run by Greenwood Genetic Center. The registered enrollment target is 100 participants.
The verdict
NCT01891422 has completed, sponsored by Greenwood Genetic Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The glycoproteinoses are among the most rare and least researched of the lysosomal diseases. The diseases include aspartylglucosaminuria, fucosidosis, galactosialidosis, alpha-mannosidosis, beta-mannosidosis, mucolipidosis II, mucolipidosis III, Schindler disease, and sialidosis. Longitudinal studies of these conditions are needed in order to better define how common the diseases are, identify clinical features which could contribute to early diagnoses, detail progression of the diseases, assess the supportive therapies currently used, and identify potential treatments. Laboratory tests will evaluate metabolic and genetic defects found in participants' blood and urine samples.
Interventions
- OTHER Non-interventional.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-08 |
| Est. Completion | 2020-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01891422
The ClinicalTrials.gov registry entry for NCT01891422 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Greenwood Genetic Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-interventional. is the first listed.
NCT01891422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01891422 about?
NCT01891422 is a clinical study titled "Longitudinal Studies of the Glycoproteinoses". The glycoproteinoses are among the most rare and least researched of the lysosomal diseases. The diseases include aspartylglucosaminuria, fucosidosis, galactosialidosis, alpha-mannosidosis, beta-mannosidosis, mucolipidosis II, mucolipidosis III, Schindler disease, and sialidosis. Longitudinal studie...
What is the current status of trial NCT01891422?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-08. Estimated completion is 2020-07.
What interventions are being tested in trial NCT01891422?
The interventions under investigation include: Non-interventional. (OTHER).
Who is sponsoring clinical trial NCT01891422?
This trial is sponsored by Greenwood Genetic Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.